Similarly, the HER2-specific Designed Ankyrin Repeat Protein (DARPin) ligand was stably expressed on HEK293 cells via lentiviral transduction, and its derived EVs effectively targeted HER2-positive SKBR3 breast cancer cells [97]. This evidence concerns the gene ERBB2 and breast carcinoma.